|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 2018加拿大心境障碍与焦虑障碍治疗协作组/国际双相障碍学会指南:双相障碍的管理显示文摘加拿大心境障碍与焦虑障碍治疗协作组(Canadian Network for Mood and Anxiety Treatments,CANMAT)曾于2005年发布了第1版双相障碍管理指南,并分别于2007、2009和2013年对该指南进行了更新,其中最近的2次更新是与国际双相障碍学会(International Society for Bipolar Disorders,ISBD)合作完成。2018版CANMAT/ISBD双相障碍治疗指南(以下简称指南)反映了自2005年首版指南发表以来本领域取得的重大进展,包括疾病诊断与疾病管理的更新以及药物治疗与心理治疗的近期研究进展。这些前沿进展中综合考虑了循证证据的级别,并基于治疗疗效、临床实践经验、安全性、耐受性和药物导致的转相风险等,对一线、二线及三线治疗方案进行了简明而清晰的推荐。本指南中新增内容涵盖了双相Ⅰ型障碍(BD-Ⅰ)的躁狂发作急性期、抑郁发作急性期和双相障碍维持期的一线及二线治疗推荐等级划分。这种对治疗推荐等级的划分综合考虑了治疗方法对双相障碍不同时相的影响,将进一步帮助临床医生做出基于循证证据的治疗决策。锂盐、喹硫平、双丙戊酸盐、阿塞那平、阿立哌唑、帕利哌酮、利培酮和卡利拉嗪单药或联合使用被推荐为躁狂发作急性期的一线治疗选择。BD-Ⅰ抑郁期的一线治疗选择包括喹硫平、鲁拉西酮、锂盐、拉莫三嗪单药,鲁拉西酮联合锂盐或双丙戊酸盐或拉莫三嗪辅助治疗。尽管急性期治疗有效的药物通常应继续用于BD-Ⅰ的维持期治疗,但也存在一些特殊情况(例如抗抑郁药)。现有数据表明,锂盐、喹硫平、双丙戊酸盐、拉莫三嗪、阿塞那平和阿立哌唑单药或联合治疗应被视为维持治疗的初始或更换治疗方案时的一线选择。除了探讨BD-Ⅰ的相关问题外,本指南中还对双相Ⅱ型障碍(BD-Ⅱ)的临床管理进行了系统回顾并给予治疗推荐,同时针对特殊人群也有相关推荐,如处于各个生殖周期的女性、儿童、青少年和老年人。此外,本指南中还讨论了特定精神疾病及共病(如物质滥用、焦虑障碍和代谢性疾病)的影响。最后,本指南中概述了安全性和药物监测的相关问题。CANMAT/ISBD工作组希望本指南能够成为全球临床医生的实用工具。 | Lakshmi N Yatham Sidney H Kennedy Sagar V Parikh Ayal Sehaffer David J Bond Benicio N Frey Verinder Sharma Benjamin I Goldstein Soham Rej Serge Beaulieu Martin Alda Glenda MaeQueen Roumen V Milev Arun Ravindran Claire O'Donovan Diane Mclntosh Raymond W Lam Gustavo Vazquez Flavio Kapczinski Roger S Melntyre Jan Kozicky Shigenobu Kanba Beny Lafer Trisha Suppes Joseph R Calabrese Eduard Vieta Gin Malhi Robert M Post Michael Berk 胡晨(译) 王刚(译) | 2019 | 中华精神科杂志2019，52，1： | 25 |
| 2 | Hemoglobin A1c in early postpartum screening of women with gestational diabetes显示文摘AIM:To assess the utility of hemoglobin A1c(HbA1c) in the early postpartum screening of women with gestational diabetes mellitus(GDM).METHODS:Over a 3 years period,HbA1c estimations were undertaken in addition to and simultaneously with the traditional oral glucose tolerance test(OGTT),in 203 women with GDM as a part of early postpartum screening for dysglycaemia,at 6 wk post-partum.World Health Organization criteria was used for diagnosing diabetes:fasting blood glucose(FBG) ≥ 7.0 mmol/Land/or 2-h postprandial blood glucose(PPBG) ≥ 11.1 mmol/L and/or HbA1c ≥ 48 mmol/mol;and impaired glycaemiastate:impaired fasting glucose 6.1-6.9 mmol/L and/or impaired glucose tolerance 7.8-11.0 mmol/L and/or HbA1c:42-47 mmol/mol.RESULTS:Mean FBG,2-h PPBG and HbA1c were 4.9 ± 0.7 mmol/L,5.6 ± 2.0 mmol/L and 38 ± 5 mmol/mol respectively.FBG,2-h PPBG and HbA1c detected 6(3%),7(3.5%) and 11(5.4%) cases of diabetes respectively,and 11(5.4%),25(12.3%) and 23(11.3%) cases of pre-diabetes state respectively.HbA1c values ≥ 48 mmol/mol(≥ 6.5%) showed a diagnostic sensitivity of 71.4% and specificity of 98.5% for diabetes in comparison to OGTT in receiver operating characteristics curve analysis.At HbA1c cut-off 44 mmol/mol,sensitivity and specificity were 100% and 92.3% respectively [area under the curve:0.98(95%CI:0.96-1.00)].Sensitivity and specificity for detecting high risk 'impaired glycaemia' state [HbA1c 42 mmol/mol(6.0%)] were 28% and 80%,respectively.CONCLUSION:HbA1c level ≥ 48 mmol/mol(≥ 6.5%) has reasonable sensitivity and high specificity in comparison to OGTT for early postpartum screening of diabetes in GDM.At 6 th week postpartum screening,if FBG is normal and HbA1c < 44 mmol/mol OGTT is not recommended. | Mahesh V Katreddy Joseph M Pappachan Sarah E Taylor Radha Indusekhar Ananth U Nayak Alan M Nevill | 2013 | World Journal of Diabetes2013，4，3： | 2 |
| 3 | Structural response of full-scale concrete box culvert显示文摘 | Ahmad M A K Maher K T Joseph V B | 1993 | Journal of Structural Engineering1993，119，11： | 1 |
| 4 | Fraudulent Financial Reporting: Consideration of Industry Traits and Corporate Governance Mechanisms 显示文摘 | Beasley M S Joseph V Carcello Dana R Hemlanson Paul D Lapides | 2000 | Accounting Horizons2000，14，4： | 1 |
| 5 | Chemokine receptor CXCR4 expression in endothelium显示文摘 | Volin M V Joseph L Shockley M S | 1998 | Biochem Biophys Res1998，242，1： | 1 |
| 6 | Prehabilitation Before Total Knee Arthroplasty Increases Strength and Function in Older Adults With Severe Osteo- arthritis 显示文摘 | Ann M Swank Joseph B Kachelman Wendy Bibeau Peter M Quesada John Nyland Arthur Malkani Robert V Topp | 2011 | Journal of Strength and Conditioning Re- search2011，2，2： | 1 |
| 7 | Recent advance in techniques for hyperspectral image processing显示文摘 | Antonio P Jon A B Joseph W B Jason B Lorenzo B Gustavo C V Jocelyn C Mathieu F Paolo G Anthony G Mattia M James C T Giovanna T | 2009 | Remote Sensing of Environment2009，113，： | 1 |
| 8 | Reaction kinetics and optimization of the copper-catalyzed oxidation of ApoA-1M 显示文摘 | Sa V H Joseph K M Kristen E T | 2009 | Chemical Engineering Science2009，64，： | 1 |
| 9 | Neurobehavior of term neonates with neonatal Hyperhilirubinemia显示文摘 | Babu T A Bhat B V Joseph N M | 2013 | J Pediatr Neurosei2013，8，1： | 1 |
| 10 | Development of human protein reference database as an initial platform for approaching systems biology in humans 显示文摘 | PERI S NAVARRO J D AMANCHY R KRISTIANSEN T Z JONNALAGADDA C K SURENDRANATH V NIRAN JAN V MUTHUSAMY B GANDHI T K GRONBORG M IBARROLA N DESHPANDE N SHANKER K SHIVASHANKAR H N RASHMI B P RAMYA M A ZHAO Z CHANDRIKA K N PADMA N HARSHA H C YATISH A J KAVITHA M P MENEZES M CHOUDHURY D R SURESH S GHOSH N SARAVANA R CHANDRAN S KRISHNA S JoY M ANAND S K MADAVAN V JOSEPH A WONG G W SCHIEMANN W P CONSTANTINESCU S N HUANG L KHOSRAVI-FAR R STEEN H TEWARI M GHAFFARI S BLOBE G C DANG C V GARCIA J G PEVSNER J JENSEN O N ROEPSTORFF P DESHPANDE K S CHINNAIYAN A M HAMOSH A CHAKRAVARTI A PANDEY A | 2003 | Genome Research2003，13，10： | 1 |
| 11 | Roles for riboflavin in the Sinorhizobium-alfalfa association显示文摘 | YANG G BHUVANESWARI T V JOSEPH C M | 2002 | Mol Plant Microbe Interact2002，15，： | 1 |
| 12 | Role of immune cells and inflammatory cytokines in regulation of fibrosis around silicone expander implants显示文摘 | JOSEPH J MOHANTY M MOHANAN P V | 2010 | J Mater Sci Mater Med2010，21，5： | 1 |
| 13 | Cognitive behavioural intervention in deliberate self-harm 显示文摘 | Raj M Joseph A Kumaraiah V Bhide AV | 2001 | Acta Psychiatr Scand2001，104，： | 1 |
| 14 | Curcumin suppresses constitutive activation of STAT-3 by up-regulating protein inhibitor of activated STAT-3 (PIAS-3) in ovarian and endometrial cancer cells 显示文摘 | SAYDMOHAMMED M JOSEPH D SYED V | 2010 | J Cell Biochem2010，110，2： | 1 |
| 15 | Sequence, organization, and expression of the human FEM1B gene 显示文摘 | Tereza V H Joseph F M | 2000 | Biochemical and Biophysical Research Communications2000，267，1： | 1 |
| 16 | Roles of salicylicacid,jasmonic acid,and ethylene in cpr-induced resistance inArabidopsis显示文摘 | Joseph D C Sigrid M V Heidi L | 2000 | Plant Cell2000，12，： | 1 |
| 17 | Models Quantify the Total Maximum Daily Load Process显示文摘 | Joseph V DePinto Paul L Freedman David M Dilks | 2004 | Journal of Environmental Engineering2004，130，6： | 1 |
| 18 | Curcumin suppresses constitutive activation of STAT-3 by up-regulating protein inhibitor of activated STAT-3(PIAS-3)in ovarian and endometrial cancer cells显示文摘 | Saydmohammed M Joseph D Syed V | 2010 | J Cell Biochem2010，110，2： | 1 |
| 19 | An analysis of multinational “audit failures”显示文摘 | Heather M Hermanson Dana R Hermanson Joseph V Carcello | 1996 | International Journal of Accounting1996，，3： | 1 |
| 20 | Curcumin suppresses constitutive activation of STAT-3 by up-regulating protein inhibitor of activated STAT-3(PIAS-3)in ovarian and endometrial cancer cells显示文摘 | Saydmohammed M Joseph D Syed V | 2010 | J Cell Biochem2010，110，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员